Baseline EEG Temporal Dynamics as a Thalamic Filter State Biomarker: A Thalamic Filter Model Account of Ketamine Antidepressant Response Prediction and Depression as Thalamic Over-Filtering
Zenodo (CERN European Organization for Nuclear Research) April 27, 2026 DOI: 10.5281/zenodo.19818580 via OpenAlex
Summary
AI-generated from the abstractA new mechanistic model called the Thalamic Filter Model (TFM) proposes that depression may involve chronically elevated inhibitory tone in the thalamic reticular nucleus, which narrows conscious bandwidth and produces cognitive rigidity and rumination. Ketamine's rapid antidepressant effect may work by temporarily reducing this thalamic over-filtering. Baseline EEG features—including vigilance stage distribution and spectral dynamics—predict ketamine response in treatment-resistant depression. A review of six independent EEG biomarker studies (total n > 200) found that lower baseline vigilance, lower gamma power, and higher alpha power all predict better response, consistent with the model's prediction that higher baseline filter impedance predicts greater benefit. The model generates three falsifiable predictions and proposes lag-1 autocorrelation as a practical baseline biomarker.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Population | Treatment-resistant depression |
| Intervention | Ketamine |
| Topics | Ketamine |
| Keywords | Baseline sea Electroencephalography Filter signal processing Thalamus |
| Key finding | Baseline EEG features indicating higher thalamic filter impedance (lower vigilance, lower gamma power, higher alpha power) predict better antidepressant response to ketamine in treatment-resistant depression. |
Abstract
Treatment-resistant depression (TRD) affects approximately 30% of major depressive disorder(MDD) cases and represents a major unmet clinical need. Ketamine produces rapid antidepressanteffects in TRD, but response is variable and no validated biomarker predicts who will respond.Multiple independent studies have now shown that baseline EEG features -- particularly vigilancestage distribution and spectral dynamics -- predict ketamine response, but no unifying mechanisticaccount of why baseline brain state should predict response to an NMDA antagonist has beenproposed. We present the Thalamic Filter Model (TFM) as a candidate mechanistic account. TheTFM proposes that depression may represent a state of thalamic over-filtering: chronicallyelevated thalamic reticular nucleus (TRN) inhibitory tone raises the thalamic impedance gate(Phi_th), narrowing conscious bandwidth and producing the cognitive rigidity, rumination, andaffective narrowing characteristic of depression. In this framework, ketamine's rapidantidepressant effect may reflect indirect TRN disinhibition via glutamatergic synapticpotentiation, transiently lowering Phi_th and expanding conscious bandwidth. Baseline EEGtemporal dynamics -- specifically lag-1 autocorrelation (AR1) and vigilance stage distribution --index individual thalamic filter state: patients with higher baseline filter impedance (lowervigilance, higher AR1) may have more room for ketamine-induced filter opening and thus greaterantidepressant response. We review published evidence from six independent ketamine EEGbiomarker studies (total n > 200) showing that lower baseline vigilance, lower baseline gammapower, and higher alpha power all predict better ketamine response -- all consistent with the TFMprediction that higher baseline filter impedance predicts greater response to filter-openingintervention. We derive three falsifiable predictions distinguishing TFM from alternative accountsand propose AR1 as a practical, low-cost baseline biomarker for ketamine response prediction.Keywords: ketamine; treatment-resistant depression; EEG biomarker; thalamic filter; thalamicreticular nucleus; AR1; autocorrelation; vigilance; antidepressant response prediction; thalamicimpedance